The predictive significance of CD20 expression in B-cell lymphomas

BACKGROUND: In our recent study, we determined the cut-off value of CD20 expression at the level of 25 000 molecules of equivalent soluble fluorochrome (MESF) to be the predictor of response to rituximab containing treatment in patients with B-cell lymphomas. In 17.5% of patients, who had the level...

Descripción completa

Detalles Bibliográficos
Autores principales: Prevodnik, Veronika Kloboves, Lavrenčak, Jaka, Horvat, Mateja, Novakovič, Barbara Jezeršek
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083324/
https://www.ncbi.nlm.nih.gov/pubmed/21486448
http://dx.doi.org/10.1186/1746-1596-6-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083324/
https://www.ncbi.nlm.nih.gov/pubmed/21486448
http://dx.doi.org/10.1186/1746-1596-6-33

Ejemplares similares